Delivery Order SPE2DB22D3016-SPE2DB24FAYJ4
- Not listed
- This federal contract award, valued at $28,482.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of dapagliflozin 10 mg tablets. The contract is a firm fixed-price delivery order that runs through December 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as the primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $31,800.57, is for the delivery of dapagliflozin 10 mg tablets and has a completion date of November 1, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,565,308,643 units of the drug dapagliflozin 10 mg tablets in 30-count packages. The contract has a ceiling value of $6,075.89 and an ultimate completion date of August 1, 2024. This contract is not set aside for any specific business category. Amerisourcebergen holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery of Dapagliflozin 10mg tablets worth $5,880.86. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $2,255.38 firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4565481167 dapagliflozin 5 mg tablets in 30-count packages. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of pharmaceutical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,557.59, is for the delivery of dapagliflozin 10 mg tablets. The contract has a period of performance through December 13, 2024 and is a firm-fixed-price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award, valued at $1,993.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dapagliflozin 10 mg tablets, a medication used to manage diabetes. The award is a Firm Fixed Price Delivery Order with a completion date of May 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $8,611.02 firm-fixed-price delivery order is for the supply of 4,565,766,279 units of the prescription drug dapagliflozin 10 mg tablets. The contract has an ultimate completion date of September 12, 2024 and does not utilize a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA...
- This federal contract award to Amerisourcebergen Drug Corp, valued at $2,486.19, provides for the delivery of 4565454992 DAPAGLIFLOZIN 10 MG TABLET 30S to the Defense Logistics Agency (DLA). The award has an ultimate completion date of August 15, 2024 and is a firm fixed-price delivery order contract. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies to supply a wide range of essential...
- This federal contract award, valued at $5,472.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAYJ4Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,482.10, is for the delivery of dapagliflozin 10 mg tablets. The award was made by the Defense Logistics Agency (DLA), which is a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. The contract award does not have a set-aside designation, indicating it was awarded on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/13/24 |